Patent №
US 7,968,115
Granted
2011-06-28
Filed 2005
Owner
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
11221179
The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated in a colloidal drug delivery system, preferably a liposomal drug delivery system. Suitable colloidal drug delivery systems also include nanoparticles, nanocapsules, microparticles or block copolymer micelles. The colloidal drug delivery system encapsulating curcumin or a curcumin analogue is administered parenterally in a pharmaceutically acceptable carrier.
AI classification
Ownership
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
assignment · 170580637
Assignors
KURZROCK, RAZELLE, LI, LAN, MEHTA, KAPIL, AGGARWAL, BHARAT
On an employer assignment, the assignors are typically the inventors.